Literature DB >> 27753008

Neurotoxicology of Synthetic Cathinone Analogs.

Mariana Angoa-Pérez1,2, John H Anneken3,4, Donald M Kuhn3,4.   

Abstract

The present review briefly explores the neurotoxic properties of methcathinone, mephedrone, methylone, and methylenedioxypyrovalerone (MDPV), four synthetic cathinones most commonly found in "bath salts." Cathinones are β-keto analogs of the commonly abused amphetamines and display pharmacological effects resembling cocaine and amphetamines, but despite their commonalities in chemical structures, synthetic cathinones possess distinct neuropharmacological profiles and produce unique effects. Among the similarities of synthetic cathinones with their non-keto analogs are their targeting of monoamine systems, the release of neurotransmitters, and their stimulant properties. Most of the literature on synthetic cathinones has focused on describing their properties as psychostimulants, their behavioral effects on locomotion, memory, and potential for abuse, whereas descriptions of their neurotoxic properties are not abundant. The biochemical gauges of neurotoxicity induced by non-keto analogs are well studied in humans and experimental animals and include their ability to induce neuroinflammation, oxidative stress, excitotoxicity, temperature alterations as well as dysregulation of neurotransmitter systems and induce changes in monoamine transporters and receptors. These neurotoxicity gauges will serve as parameters to discuss the effects of the four previously mentioned synthetic cathinones alone or in combination with either another cathinone or with some of their non-keto analogs. Bath salts are not a defined combination of drugs and may consist of one synthetic cathinone compound or combinations of more cathinones. Furthermore, this review also presents some of the mechanisms that are thought to underlie this toxicity. A better understanding of the cellular and molecular mechanisms involved in the synthetic cathinones-induced neurotoxicity should contribute to generate modern therapeutic approaches to prevent or attenuate the adverse consequences of use of these drugs in humans.

Entities:  

Keywords:  MDPV; Mephedrone; Methcathinone; Methylone; Neurotoxicity; Synthetic cathinones

Mesh:

Substances:

Year:  2017        PMID: 27753008      PMCID: PMC6100737          DOI: 10.1007/7854_2016_21

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  97 in total

1.  Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques.

Authors:  R D Crean; S A Davis; S N Von Huben; C C Lay; S N Katner; M A Taffe
Journal:  Neuroscience       Date:  2006-07-28       Impact factor: 3.590

2.  Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone.

Authors:  Raúl López-Arnau; José Martínez-Clemente; Teresa Rodrigo; David Pubill; Jorge Camarasa; Elena Escubedo
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-24       Impact factor: 4.219

3.  3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.

Authors:  John H Anneken; Mariana Angoa-Pérez; Donald M Kuhn
Journal:  J Neurochem       Date:  2015-03-02       Impact factor: 5.372

4.  In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats.

Authors:  Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2015-05-01       Impact factor: 4.530

5.  Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.

Authors:  Raul López-Arnau; Jose Martínez-Clemente; David Pubill; Elena Escubedo; Jorge Camarasa
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

6.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

7.  Acute Methylenedioxypyrovalerone Toxicity.

Authors:  Blake A Froberg; Michael Levine; Michael C Beuhler; Bryan S Judge; Philip W Moore; Kristin M Engebretsen; Nathanael J Mckeown; Christopher D Rosenbaum; Amy C Young; Daniel E Rusyniak
Journal:  J Med Toxicol       Date:  2015-06

8.  Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia.

Authors:  S E Shortall; A R Green; K M Swift; K C F Fone; M V King
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

9.  Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone.

Authors:  Bjørnar den Hollander; Mira Sundström; Anna Pelander; Ilkka Ojanperä; Eero Mervaala; Esa Risto Korpi; Esko Kankuri
Journal:  Toxicol Sci       Date:  2014-06-09       Impact factor: 4.849

10.  Methylone and monoamine transporters: correlation with toxicity.

Authors:  Chiharu Sogawa; Norio Sogawa; Kazumi Ohyama; Ruri Kikura-Hanajiri; Yukihiro Goda; Ichiro Sora; Shigeo Kitayama
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

View more
  20 in total

1.  Emerging threats in addiction: will novel psychoactive substances contribute to exacerbating the ongoing drug overdose epidemic?

Authors:  F Scott Hall; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2019-03       Impact factor: 4.530

Review 2.  Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

Authors:  Michael H Baumann; Mohammad O Bukhari; Kurt R Lehner; Sebastien Anizan; Kenner C Rice; Marta Concheiro; Marilyn A Huestis
Journal:  Curr Top Behav Neurosci       Date:  2017

3.  Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Kaveish Sewalia; Lucas R Watterson; Alyssa Hryciw; Anna Belloc; J Bryce Ortiz; M Foster Olive
Journal:  Neuropharmacology       Date:  2017-11-26       Impact factor: 5.250

4.  Detrimental effects of the 'bath salt' methylenedioxypyrovalerone on social play behavior in male rats.

Authors:  Sara Schiavi; Francesca Melancia; Emilia Carbone; Valeria Buzzelli; Antonia Manduca; Patricia Jiménez Peinado; Clemens Zwergel; Antonello Mai; Patrizia Campolongo; Louk J M J Vanderschuren; Viviana Trezza
Journal:  Neuropsychopharmacology       Date:  2020-06-07       Impact factor: 7.853

Review 5.  Psychoactive Bath Salts and Neurotoxicity Risk.

Authors:  Beril Altun; İsmet Çok
Journal:  Turk J Pharm Sci       Date:  2020-04-24

6.  Problem-solving deficits in methcathinone use disorder.

Authors:  Hang-Bin Zhang; Di Zhao; Yu-Ping Liu; Li-Xun Wang; Bo Yang; Ti-Fei Yuan
Journal:  Psychopharmacology (Berl)       Date:  2021-07-22       Impact factor: 4.530

7.  Binge-like acquisition of α-pyrrolidinopentiophenone (α-PVP) self-administration in female rats.

Authors:  Mehrak Javadi-Paydar; Eric L Harvey; Yanabel Grant; Sophia A Vandewater; Kevin M Creehan; Jacques D Nguyen; Tobin J Dickerson; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2018-06-16       Impact factor: 4.530

8.  Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats.

Authors:  Mehrak Javadi-Paydar; Jacques D Nguyen; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe
Journal:  Neuropharmacology       Date:  2017-09-04       Impact factor: 5.250

9.  Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells.

Authors:  Teresa Coccini; Sarah Vecchio; Marta Crevani; Uliana De Simone
Journal:  Neurotox Res       Date:  2018-06-22       Impact factor: 3.911

Review 10.  Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?

Authors:  Jonna M Leyrer-Jackson; Erin K Nagy; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2018-10-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.